ATE533776T1 - Analoge verbindungen analgetischer peptide, abgeleitet vom crotalus durissus terrificus schlangengift, ihre verwendungen, zusammensetzungen und verfahren ihrer herstellung und reinigung - Google Patents

Analoge verbindungen analgetischer peptide, abgeleitet vom crotalus durissus terrificus schlangengift, ihre verwendungen, zusammensetzungen und verfahren ihrer herstellung und reinigung

Info

Publication number
ATE533776T1
ATE533776T1 AT05738454T AT05738454T ATE533776T1 AT E533776 T1 ATE533776 T1 AT E533776T1 AT 05738454 T AT05738454 T AT 05738454T AT 05738454 T AT05738454 T AT 05738454T AT E533776 T1 ATE533776 T1 AT E533776T1
Authority
AT
Austria
Prior art keywords
purification
preparation
methods
compositions
compounds derived
Prior art date
Application number
AT05738454T
Other languages
English (en)
Inventor
Yara Cury
Gisele Picolo
Katsuhiro Konno
Renata Giorgi
Patricia Brigatte
Vanessa Gutierrez
Antonio Camargo
Original Assignee
Laboratorios Biosintetica Ltda
Fundacaeo De Amparo A Pesquisa Do Estado De Saeo Paulo Fapesp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BRPI0502399-8A external-priority patent/BRPI0502399B1/pt
Application filed by Laboratorios Biosintetica Ltda, Fundacaeo De Amparo A Pesquisa Do Estado De Saeo Paulo Fapesp filed Critical Laboratorios Biosintetica Ltda
Application granted granted Critical
Publication of ATE533776T1 publication Critical patent/ATE533776T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2842—Pain, e.g. neuropathic pain, psychogenic pain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Addiction (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
AT05738454T 2004-05-06 2005-05-06 Analoge verbindungen analgetischer peptide, abgeleitet vom crotalus durissus terrificus schlangengift, ihre verwendungen, zusammensetzungen und verfahren ihrer herstellung und reinigung ATE533776T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BRPI0401702 2004-05-06
BRPI0502399-8A BRPI0502399B1 (pt) 2005-05-02 2005-05-02 Compostos análogos a peptídeos analgésicos derivados de veneno de serpentes crotalus durissus terrificus, seus usos, composições, métodos de preparação e de puruficação
PCT/BR2005/000073 WO2005107357A2 (en) 2004-05-06 2005-05-06 Analgesic peptides derived from the venom of crotalus durissus terrificuss snakes

Publications (1)

Publication Number Publication Date
ATE533776T1 true ATE533776T1 (de) 2011-12-15

Family

ID=37625965

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05738454T ATE533776T1 (de) 2004-05-06 2005-05-06 Analoge verbindungen analgetischer peptide, abgeleitet vom crotalus durissus terrificus schlangengift, ihre verwendungen, zusammensetzungen und verfahren ihrer herstellung und reinigung

Country Status (10)

Country Link
US (1) US9109041B2 (de)
EP (1) EP1765851B1 (de)
JP (1) JP4777344B2 (de)
CN (1) CN101048170B (de)
AT (1) ATE533776T1 (de)
AU (1) AU2005239771B2 (de)
CA (1) CA2565731C (de)
ES (1) ES2377635T3 (de)
PT (1) PT1765851E (de)
WO (1) WO2005107357A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1765851B1 (de) * 2004-05-06 2011-11-16 Laboratório Biosintética Ltda. Analoge Verbindungen analgetischer Peptide, abgeleitet vom Crotalus durissus terrificus Schlangengift, ihre Verwendungen, Zusammensetzungen und Verfahren ihrer Herstellung und Reinigung
CA2685720C (en) * 2007-05-01 2016-07-05 Fundacao De Amparo A Pesquisa Do Estado De Sao Paulo - Fapesp Analgesic compounds
ES2598829T3 (es) * 2011-03-28 2017-01-30 S.I.S. Shulov Innovative Science Ltd. Procedimiento de tratamiento de trastornos cutáneos
BR102014011436A8 (pt) * 2014-05-12 2018-01-09 Univ Estadual Paulista Julio De Mesquita Filho selante de fibrina para uso tópico, método de formação do mesmo e seu uso
BR102014011432B1 (pt) * 2014-05-12 2022-06-07 Universidade Estadual Paulista Julio De Mesquita Filho Arcabouço tridimensional para células tronco, processo de obtenção do mesmo e seu uso
BR102016023153A2 (pt) * 2016-10-04 2018-05-02 Fundação Butantan Composição, uso, e, método para tratar doenças neurodegenerativas
WO2026025169A1 (en) * 2024-08-02 2026-02-05 Instituto Butantan Peptide derived from crotalphine, composition comprising the said peptide, its use and method to treat acute or chronic pain

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1184164B (it) 1985-03-19 1987-10-22 Eniricerche Spa Triptidi ad azione ipotensiva e procedimento per la loro sintesi
EP0246861B1 (de) * 1986-05-19 1993-03-17 Ventech Research, Inc. Verwendung von Zusammensetzungen auf Basis von Crotoxin, zur Herstellung von Medikamenten zur Behandlung von Carcinomen
US5164196A (en) * 1987-05-19 1992-11-17 Ventech Research, Inc. Crotoxin complex as cytotoxic agent
WO1991001740A1 (en) 1989-08-05 1991-02-21 Varánusz Gm Process for producing pharmacosmetics
US5232911A (en) * 1990-01-03 1993-08-03 Ventech Research Inc. Mixture of a non-covalent heterodimer complex and a basic amphiphatic peptide as cytotoxic agent
US5439884A (en) 1992-07-27 1995-08-08 Oregon Regional Primate Research Center Method of controlling fertilization using bombesin or its agonist
US5866346A (en) * 1995-09-27 1999-02-02 Indiana Unversity Foundation Methods of using dynorphins as ligands for XOR1 receptor
IL123001A (en) 1998-01-20 1998-12-06 Shulov Inst For Venom Research Analgesic fraction from snake March and pharmacy preparations containing it
EP1765851B1 (de) * 2004-05-06 2011-11-16 Laboratório Biosintética Ltda. Analoge Verbindungen analgetischer Peptide, abgeleitet vom Crotalus durissus terrificus Schlangengift, ihre Verwendungen, Zusammensetzungen und Verfahren ihrer Herstellung und Reinigung
CA2685720C (en) * 2007-05-01 2016-07-05 Fundacao De Amparo A Pesquisa Do Estado De Sao Paulo - Fapesp Analgesic compounds

Also Published As

Publication number Publication date
WO2005107357A2 (en) 2005-11-17
CN101048170B (zh) 2011-04-13
JP2008504234A (ja) 2008-02-14
AU2005239771B2 (en) 2011-03-10
PT1765851E (pt) 2012-01-06
JP4777344B2 (ja) 2011-09-21
WO2005107357A3 (en) 2007-05-24
CA2565731C (en) 2015-07-07
CA2565731A1 (en) 2005-11-17
CN101048170A (zh) 2007-10-03
US9109041B2 (en) 2015-08-18
EP1765851A2 (de) 2007-03-28
ES2377635T3 (es) 2012-03-29
US20090203618A1 (en) 2009-08-13
AU2005239771A1 (en) 2005-11-17
EP1765851B1 (de) 2011-11-16
EP1765851A4 (de) 2008-05-28

Similar Documents

Publication Publication Date Title
EP1469810A4 (de) Zusammensetzungen und verfahren zur verhütung und behandlung von erkrankungen im zusammenhang mit amyloid-beta peptid
UA103154C2 (uk) Hla-a*1101-обмежений пептид wt1 і фармацевтична композиція, яка містить його
AR062065A1 (es) Anticuerpo humanizado
NZ599161A (en) Method for activation of helper t cell and composition for use in the method
WO2011149964A3 (en) Methods for treating or preventing vascular graft failure
JP2006506942A5 (de)
MX2008009493A (es) Peptido novedoso y uso del mismo.
ATE506957T1 (de) Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen
WO2009038026A1 (ja) Ｃｔｌ誘導剤組成物
ATE463257T1 (de) Zusammensetzungen zur vorbeugung und behandlung von erkältung und influenza-ähnlichen erscheinungen enthaltend ausgewählte mukadhäsive polymere
FR2861731B1 (fr) Nouvelle proteine de fixation du phosphate, compositions pharmaceutiques la contenant et ses utilisations
ATE533776T1 (de) Analoge verbindungen analgetischer peptide, abgeleitet vom crotalus durissus terrificus schlangengift, ihre verwendungen, zusammensetzungen und verfahren ihrer herstellung und reinigung
ATE536745T1 (de) Zusammensetzung mit arazym zur prävention und behandlung von krebs
WO2008047370A3 (en) Compositions and methods for inducing angiogenesis
NO20081453L (no) Sammensetninger og fremgangsmater for diagnostisering og behandling av inflammasjon
WO2008070049A3 (en) Peptide and treatment for hiv-1 infection
WO2009010957A3 (en) Heparanase c-terminal domain, sequences derived therefrom, substances directed against said domain and uses thereof as modulators of heparanase biological activity
BRPI0502399A (pt) compostos análogos a peptìdeos analgésicos derivados de veneno de serpentes crotalus durissus terrificus, seus usos, composições, métodos de preparação e de puruficação
ATE411812T1 (de) Peptide zur behandlung von infektionen mit dem herpes-virus
ATE538806T1 (de) Peptide mit spezifischem sitz in herzgefässen und verwandte konjugate und verfahren
NO20052525D0 (no) Spleisevariant av humant hypofyseveksthormon
DE602005017391D1 (de) Verwendung von peptid-mimotopen von mannosylierten lipoglycanen aus mycobacterien zur behandlung von entzündungen
ATE491947T1 (de) Peptid zur hemmung von calcineurin
WO2005087809B1 (en) Peptides from vitronectin and their therapeutic exploitation for osteoblast adhesion
EA200501843A1 (ru) Tnf-подобный секретируемый белок